EVERSANA expands commercialisation portfolio with OS Therapies and Iterum Therapeutics partnerships

#EVERSANA #OSTherapies #IterumTherapeutics #OSTHER2 #paediatricosteosarcoma #immunotherapy #OrphanDesignation #FastTrackDesignation #RarePediatricDiseaseDesignation #BLAsubmission #EVERSANAONCOLOGY #ORLYNVAH #ProductCommercializationAgreement #oralpenemantibiotic
pharmaphorum.com/market-acces...